The Prevalence and Risk Factors of Cardiovascular Comorbidity in Patients with Severe and Very Severe COPD

Jagoda Stojkovikj; Beti Ivanovska-Zafirovska; Irina Angelovska; Angela Debreslioska; Sead Zejnel

Authors

Jagoda Stojkovikj
Beti Ivanovska-Zafirovska
Irina Angelovska
Angela Debreslioska
Sead Zejnel

Keywords:

severe COPD, very severe COPD, risk factors, cardiovascular comorbidity

Abstract

Cardiovascular comorbidities are most frequent comorbidities in COPD and are responsible for many deaths in those patients. The aim of the study was to investigate the prevalence and the risk factors of these comorbidities. In the survey 114COPD patients were included with severe and very severe stage of the disease, FEV1

Downloads

How to Cite

The Prevalence and Risk Factors of Cardiovascular Comorbidity in Patients with Severe and Very Severe COPD. (2016). Global Journal of Medical Research, 16(F4), 7-13. https://medicalresearchjournal.org/index.php/GJMR/article/view/1143

Download Citation

References

David Mannino (2002) COPD. 121(5), 121S-126S.

Stephen Sidney, Michael Sorel, Charles Quesenberry, Cynthia Deluise, Stephan Lanes, Mark Eisner (2005) COPD and Incident Cardiovascular Disease Hospitalizations and Mortality: Kaiser Permanente Medical Care Program. 128(4), 2068-2075.

I Andriana (2015) Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk. 46, 846-849.

C Arnaud (2013) Comorbidities of COPD. 22, 454-475.

E Dionne (2015) Impact of cardiovascular comorbidities on COPD Assessment Test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study. 5(7), 7536.

J Izquierdo (2010) Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors. 8(5), 387-394.

F Michael (2012) Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). 7, 679-686.

W Vandijk (2009) Interaction in COPD experiment (ICE): a hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease. 74(2), 277-280.

D Sin, S Man (2005) Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. 83(1), 8-13.

Don Sin, Sf Man (2008) Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease. 14(2), 115-121.

Carlos Martinez, David Mannino, Miguel Divo (2014) Defining COPD-Related Comorbidities, 2004-2014. 1(1), 51-63.

Peter Barnes (2010) Chronic Obstructive Pulmonary Disease: Effects beyond the Lungs. 7(3), e1000220.

Don Sin, S Man (2005) Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality. 2(1), 8-11.

D Mannino, D Thorn, A Swensen, F Holguin (2008) Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. 32(4), 962-969.

R Langen, H Gosker, A Remels, A Schols (2013) Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. 45(10), 2245-2256.

Michael Donahoe, Robert Rogers, David Wilson, Bernard Pennock (1989) Oxygen Consumption of the Respiratory Muscles in Normal and in Malnourished Patients with Chronic Obstructive Pulmonary Disease. 140(2), 385-391.

Li Wei, M (2004) Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease. 141(10), 764-770.

T Perez (2015) Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. 10, 1663-1672.

H Müllerová (2014) Prevalence and Burden of Breathlessness in Patients with Chronic Obstructive Pulmonary Disease Managed in Primary Care. 9(1), 85540.

Hans Van Remoortel, Miek Hornikx, Daniel Langer, Chris Burtin, Stephanie Everaerts, Peter Verhamme, Steven Boonen, Rik Gosselink, Marc Decramer, Thierry Troosters, Wim Janssens (2014) Risk Factors and Comorbidities in the Preclinical Stages of Chronic Obstructive Pulmonary Disease. 189(1), 30-38.

Wenjia Chen, Jamie Thomas, Mohsen Sadatsafavi, J Fitzgerald (2015) Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. 3(8), 631-639.

L Roever, E Resende (2015) Cardiovascular Comorbidities in COPD Patients. 5, 151.

Paul Jones, Lukasz Adamek, Gilbert Nadeau, Norbert Banik (2013) Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. 42(3), 647-654.

M Masaki (2014) Analysis of comorbid factors that increase the COPD assessment test scoresRespir. 15(1), 13.

Sang-Do Lee, Ming-Shyan Huang, Jian Kang, Ching-Hsiung Lin, Myung Park, Yeon-Mok Oh, Namhee Kwon, Paul Jones, Dimitar Sajkov (2014) The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients. 108(4), 600-608.

P Jones (2009) Development and first validation of the COPD Assessment Test. 34, 648-654.

N Sarioglu, A Hismiogullari, C Bilen, F Erel (2016) Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD?. 22(1), 11-17.

Martin Macdonald, Eskandarain Shafuddin, Paul King, Catherina Chang, Philip Bardin, Robert Hancox (2016) Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease. 4(2), 138-148.

C Terzano (2010) Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. 188(4), 321-329.

S Man (2006) C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. 61(10), 849-853.

Susheel Patil, Jerry Krishnan, Noah Lechtzin, Gregory Diette (2003) In-Hospital Mortality Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease. 163(10), 1180.

A Wong (2008) Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates. 15(7), 361-364.

R Kessler (1999) Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. 159(1), 158-164.